Cell Culture Technology– category –
-
Gene-Edited iPSC-Derived CAR-T/NK Therapies Target Allogeneic Rejection for Off-the-Shelf Cancer Immunotherapy
MDPI Switzerland Overview Allogeneic T cell therapies represent a scalable, off-the-shelf alternative to autologous approaches, promising to overcome significant logistical and manufacturing limitations. The review highlights iPSC-derive... -
European Biotechs Unveil Next-Gen CGT Manufacturing to Cut CAR-T Costs Above €60,000 Per Patient
PharmTech Global Overview European biopharmaceutical companies are spearheading the development of advanced manufacturing technologies to address the high costs and logistical hurdles of Cell and Gene Therapies (CGT). Innovations include... -
Cell Culture Technology Weekly Report June 27, 2026
▼ ▼ ▼ If the infographic makes you want to read the full report, please click the download button below. ▼ ▼ ▼ 📄 Weekly Report June 27, 2026 (PDF) — Download Weekly Report June 27, 2026 (PDF) — DownloadDownload 🎙 Podcast June 27, 2026 (... -
Cell Therapy Scale-Up and CDMO Staff Reductions Trigger Critical Process Know-How Loss in Tech Transfer
Drug Discovery and Development USA Overview The scaling of cell therapies, coupled with staffing changes at Contract Development and Manufacturing Organizations (CDMOs), is leading to a significant loss of critical process know-how durin... -
CAR-T Cell Therapy for Autoimmune Diseases Achieves 40-60% Cost Reduction and Sub-7-Day Manufacturing Through Gene Editing and Process Optimization
Market Intelo USA Overview Advances in gene-editing technologies are significantly reducing alloreactivity risk in allogeneic CAR-T products and cutting production costs by an estimated 40-60%. Next-generation allogeneic platforms aim to... -
Syntax Bio and Applied StemCell Partner to Accelerate Allogeneic Cell Therapies with GMP-Compliant Hypoimmune iPSCs and Cellgorithm Platform
CRISPR Medicine News USA Overview Syntax Bio and Applied StemCell have forged a strategic collaboration to propel next-generation regenerative medicine by advancing stem cell innovation. Applied StemCell will supply GMP-compatible hypoim... -
arXiv Paper: Raman Data Fusion with Latent ODE Enhances Cell Culture Process Forecasting Accuracy
arXiv (Preprint) Global Overview New research published on arXiv proposes an innovative approach to improve cell culture process forecasting accuracy by fusing Raman spectroscopy data with a 'Multipath Adaptive Gated Bottleneck Latent OD... -
Data Integrity in Bioprocessing: ALCOA+ Compliance Critical for Ensuring Reliability of GMP Records
Lab Manager Global Overview In bioprocessing labs, data integrity and adherence to ALCOA+ principles are critical for meeting regulatory expectations and ensuring product safety and efficacy. All GMP records, including those from bioreac... -
In-Line Sensors Play Crucial Role in Single-Use Biomanufacturing, Driving PAT Adoption and Enhancing Process Control
Technology Networks Global Overview In-line sensors are proving indispensable in single-use biomanufacturing for improving process efficiency and reliability. Directly integrated into single-use bioreactor bags, these sensors enable cont... -
Bioprocessing Technologies Reshape Food Production, Environmental Applications, and Sustainable Manufacturing Beyond Pharma
Technology Networks Global Overview Bioprocessing technologies are redefining various industries beyond pharmaceuticals, including food production, environmental applications, and sustainable manufacturing. Key technologies like fermenta...
